Papers

2

Total Citations

75

H-Index

2

About

Charles Bonney is a pioneering researcher at the intersection of stem cell biology and automation, whose work is redefining how human pluripotent stem cells (hiPSCs) are manufactured for therapeutic and research applications. His primary research areas include high-throughput biomanufacturing, robotic cell culture systems, and the functional differentiation of stem cells. Bonney’s major contribution lies in developing scalable, robotic platforms that replace traditional manual cell culture—a process notoriously variable and labor-intensive. His most-cited paper (2021, 68 citations) demonstrates a fully automated system capable of robust hiPSC self-renewal and differentiation, addressing a critical bottleneck in translating stem cell therapies from lab to clinic. This work, along with a related 2020 publication (7 citations), showcases his ability to merge engineering precision with biological complexity, significantly reducing human error and increasing reproducibility. By enabling high-throughput, consistent biomanufacturing, Bonney’s innovations are accelerating the path toward affordable, large-scale production of cells for regenerative medicine, drug screening, and disease modeling—a transformative achievement for the field.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells
68 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Advancing Translational Sciences, National Institutes of Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago